DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: KESIMPTA (ofatumumab)
       *****************************************************
       #Post#: 5045--------------------------------------------------
       T lymphopenia in MS patients treated with ofatumumab
       By: agate Date: January 5, 2026, 1:17 am
       ---------------------------------------------------------
       MS drugs have their risks. This was a small study but T
       lymphopenia sounds as if it could be serious. From AI:
       [quote]T lymphopenia is [font=google sans]a condition where
       there's an abnormally low count of T-cells,, a crucial type of
       lymphocyte (white blood cell) that fights infections and
       abnormal cells, making the immune system weaker and increasing
       susceptibility to illness[/font][font=google sans]. It's a
       specific type of  lymphopenia[/font][font=google sans] (low
       lymphocytes) and can stem from genetic issues, severe viral
       infections (like HIV, COVID-19), autoimmune diseases,
       malnutrition, or treatments like chemotherapy, leading to
       recurrent infections.[/font][/quote]\
       From Multiple Sclerosis Journal - Experimental, Translational
       and Clinical (January 2, 2026)--"T lymphopenia in MS patients
       treated with ofatumumab":
  HTML https://journals.sagepub.com/doi/full/10.1177/20552173251409954
       *****************************************************